Need for optimized dosages in the design of comparative clinical trials of anti-malarial drugs

Abstract

Abstract We read with interest the publication on malaria treatment by Obonyo et al. (Malaria J 21:30, 2022). This commentary questions the methodology, especially the chosen time points of treatment outcome measures.

Keywords

• Artemether–lumefantrine
• Children
• Clindamycin
• Kenya
• Malaria
• Quinine